Table 2 Means, standard deviations M(SD) and comparisons between CE and non-CE patients on ED symptoms, patient characteristics and clinical features, in women and men separately. Effect sizes reported for significant results, meaningful effects (≥ small) in bold. N varies for each analysis due to missing data in one or more variables

8740

4.2 (1.0)

3.6 (1.3)

522.73^***

.056

334

3.6 (1.1)

3.0 (1.3)

18.50^***

.053

8740

4.0 (1.3)

3.1 (1.7)

771.73^***

.081

334

3.4 (1.5)

2.6 (1.7)

19.90^***

.057

4870

11.0 (10.7)

12.8 (12.1)

32.42^***

.007

181

11.8 (11.9)

12.6 (14.4)

.18

4257

16.2 (17.8)

20.8 (23.8)

51.53^***

.012

121

19.5 (21.5)

26.3 (33.7)

1.72

8740

25.3 (7.1)

27.1 (8.9)

109.16^***

.012

334

27.9 (9.6)

27.7 (10.1)

.13

4193

16.2 (4.5)

16.1 (5.3)

.06

178

20.1 (8.0)

17.4 (5.6)

7.18^**

.039

4193

9.2 (7.8)

11.3 (9.4)

57.57^***

.014

178

8.0 (8.0)

10.1 (10.7)

2.16

8736

21.4 (4.2)

22.9 (7.2)

141.22^***

.016

334

23.4 (6.3)

24.5 (9.0)

1.64

8740

11.1 (4.7)

10.6 (4.8)

23.60^***

.003

334

10.4 (4.9)

9.9 (4.8)

.88

8740

10.0 (4.3)

9.5 (4.3)

21.96^***

.003

334

8.9 (4.4)

8.7 (4.2)

.15

8740

9.6 (4.3)

9.0 (4.3)

52.92^***

.006

334

9.2 (4.6)

8.4 (4.5)

2.79

8735

1.7 (1.4)

1.6 (1.5)

2.47

332

1.6 (1.4)

1.6 (1.5)

<.01

8740

−15.6 (34.5)

−12.2 (36.4)

19.66^***

.002

334

−5.0 (39.3)

−2.0 (39.1)

.51

8740

60.0 (22.5)

55.2 (23.7)

94.97^***

.011

334

54.3 (24.4)

48.3 (24.4)

5.00^*

.015